Your browser doesn't support javascript.
loading
High-dose methotrexate, thiotepa, orelabrutinib combined with or without rituximab in primary or secondary central nervous system diffuse large B-cell lymphoma: a single-center retrospective analysis.
Li, Yufeng; Li, Yajun; Zeng, Ruolan; He, Yizi; Liang, Liang; Ou, Lijia; Su, Chang; Zhou, Hui; Xiao, Ling.
Afiliación
  • Li Y; Central South University, Department of Lymphoma & Hematology, The Affiliated Tumor Hospital of Xiangya Medical School, Changsha, Hunan, China.
  • Li Y; Department of Histology and Embryology of School of Basic Medical Science, Central South University, Changsha, Hunan, China.
  • Zeng R; Central South University, Department of Lymphoma & Hematology, The Affiliated Tumor Hospital of Xiangya Medical School, Changsha, Hunan, China.
  • He Y; Central South University, Department of Lymphoma & Hematology, The Affiliated Tumor Hospital of Xiangya Medical School, Changsha, Hunan, China.
  • Liang L; Central South University, Department of Lymphoma & Hematology, The Affiliated Tumor Hospital of Xiangya Medical School, Changsha, Hunan, China.
  • Ou L; Central South University, Department of Lymphoma & Hematology, The Affiliated Tumor Hospital of Xiangya Medical School, Changsha, Hunan, China.
  • Su C; Department of Histology and Embryology of School of Basic Medical Science, Central South University, Changsha, Hunan, China.
  • Zhou H; Department of Histology and Embryology of School of Basic Medical Science, Central South University, Changsha, Hunan, China.
  • Xiao L; Central South University, Department of Lymphoma & Hematology, The Affiliated Tumor Hospital of Xiangya Medical School, Changsha, Hunan, China.
J Cancer ; 14(17): 3182-3190, 2023.
Article en En | MEDLINE | ID: mdl-37928429

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Cancer Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Cancer Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Australia